United States · Funded startup

Who invested in VertiFlex

9 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$107Mraised across 9 rounds since 2007, from 9 sources

$20MSeries B$8.0MDebt$2.0MDebt$14MVenture$8.0MVenture$4.0MDebt$6.0MDebt$4.8MDebt$40MRound
Latest round
Round, $40MMar 2017
Step-upi
8.3×
Investors
8
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200720092011201320152017
$20MSeries B$8.0MDebt$2.0MDebt$14MVenture$8.0MVenture$4.0MDebt$6.0MDebt$4.8MDebt$40MRound
First round
Series B, $20M
Jan 2007
Biggest round
$40M
Round · Mar 2017
Usual gap between rounds
13 months
the median of 8

The rounds

  1. Mar 2017
    Round$40M5 new

    Reported by FinSMEsSEC filing: $25M sold, first sale Mar 2017

  2. Jul 2015
    Debt$4.8M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.8M sold, first sale Jul 2015

  3. Oct 2014
    Debt$6.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $6.0M sold, first sale Sept 2014

  4. Aug 2013
    Debt$4.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $4.0M sold, first sale Aug 2013

  5. Jan 2012
    Venture$8.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $8.0M sold, first sale Jan 2012

  6. Feb 2011
    Venture$14M

    No investor was named in the report.

    Reported by fis.dowjones.comSEC filing: $14M sold, first sale Dec 2010

  7. Jul 2010
    Debt$2.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $2.0M sold, first sale Jul 2010

  8. Jul 2009
    Debt$8.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $8.0M sold, first sale Jul 2009

  9. Jan 2007
    Series B$20M3 new

    From a historical funding record

Founders and team

From the SEC filings it signed: 2 on the team.

  • Earl R. FenderExecutive Officer, Directori
  • Jeff R. SwieckiExecutive Officeri

On the board, as filediAlexander Justin SchmitzKathy Justin TuneMichael Justin WassermanPeter Justin KleinRay Justin Baker

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2009Debt2010Venture2011Venture2012Debt2013Debt2014Debt2015Round2017Morgenthaler VenturesAlta PartnersAberdare VenturesAltaH.I.G. BioHealth PartnersTHOMAS FUNDEndeavour Vision/ New Enterprise AssociatesMcNerney & Partners

Everyone who backed them

Alta PartnersVC firm1round
Aberdare VenturesVC firm1round
AltaVC firm1round
THOMAS FUNDInvestment firm1round
Endeavour Vision/ New Enterprise Associatesno record of our own yet1round
McNerney & Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about VertiFlex

Who invested in VertiFlex?

VertiFlex's investors include Morgenthaler Ventures, Alta Partners, Aberdare Ventures, Alta and H.I.G. BioHealth Partners, and 3 more on record.

How much has VertiFlex raised?

VertiFlex has raised $107M across 9 rounds since 2007.

When did VertiFlex last raise?

VertiFlex's most recent round was an Undisclosed round of $40M in Mar 2017.

What was VertiFlex's biggest round?

Its most recent round, $40M in Mar 2017, is also its largest on record.

Who backed VertiFlex first?

VertiFlex's first round on record, in Jan 2007, was backed by Morgenthaler Ventures, Alta Partners and Aberdare Ventures.

What stage is VertiFlex at?

VertiFlex's latest named round is an Undisclosed round, in Mar 2017.

Where is VertiFlex based?

VertiFlex is based in the United States.

Companies like VertiFlex

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.